Stomach cancer is a master of survival. New research explains how it outsmarts the immune system, making immunotherapy less effective.
The tumor creates a harsh environment: low oxygen, high acid, and few nutrients. Cancer cells gobble up what little fuel is available, leaving immune cells starving and weak. Meanwhile, the tumor pumps out waste products like lactic acid, adenosine, kynurenine, and prostaglandin E2. These metabolites act as chemical weapons, suppressing immune function and helping the cancer evade attack.
This review describes the metabolic reprogramming that happens in the tumor microenvironment. It's a theoretical framework, not a clinical trial. The findings are based on a narrative review of existing research, so the certainty is low. There are no specific drug results or patient outcomes reported.
Still, the work points to potential new targets for therapy. By disrupting these metabolic tricks, doctors might one day make immunotherapy work better for people with gastric cancer.
Common questions
What is metabolic reprogramming in stomach cancer?
It's a process where cancer cells change how they use nutrients and produce waste. In the tumor, this creates a harsh environment with low oxygen and high acid. Cancer cells compete with immune cells for food and release metabolites like lactic acid that weaken the immune response.
How does this affect immunotherapy for stomach cancer?
The metabolic changes in the tumor can make immunotherapy less effective. The waste products from cancer cells suppress immune cells, helping the tumor evade attack. This review suggests that targeting these metabolic pathways might improve how well immunotherapy works.
Is this research based on human trials?
No, this is a narrative review, not a clinical trial. It summarizes existing research on how metabolism affects the tumor environment. The findings are theoretical and have low certainty. No specific drug results or patient outcomes are reported.
What are the main metabolites involved?
The review identifies lactic acid, adenosine, kynurenine, and prostaglandin E2 as key metabolites that build up in the tumor. These substances can suppress immune function and help cancer cells escape detection and treatment.
